471 related articles for article (PubMed ID: 34385685)
1. Next-generation cancer organoids.
LeSavage BL; Suhar RA; Broguiere N; Lutolf MP; Heilshorn SC
Nat Mater; 2022 Feb; 21(2):143-159. PubMed ID: 34385685
[TBL] [Abstract][Full Text] [Related]
2. Toward reproducible tumor organoid culture: focusing on primary liver cancer.
Guo L; Li C; Gong W
Front Immunol; 2024; 15():1290504. PubMed ID: 38571961
[TBL] [Abstract][Full Text] [Related]
3. Emerging organoid models: leaping forward in cancer research.
Fan H; Demirci U; Chen P
J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy.
Wu W; Li X; Yu S
Acta Biomater; 2022 Jul; 146():23-36. PubMed ID: 35533925
[TBL] [Abstract][Full Text] [Related]
5. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.
Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T
Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
7. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
8. Automation of Organoid Cultures: Current Protocols and Applications.
Louey A; Hernández D; Pébay A; Daniszewski M
SLAS Discov; 2021 Oct; 26(9):1138-1147. PubMed ID: 34167363
[TBL] [Abstract][Full Text] [Related]
9. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity.
Jiang S; Zhao H; Zhang W; Wang J; Liu Y; Cao Y; Zheng H; Hu Z; Wang S; Zhu Y; Wang W; Cui S; Lobie PE; Huang L; Ma S
Cell Rep Med; 2020 Dec; 1(9):100161. PubMed ID: 33377132
[TBL] [Abstract][Full Text] [Related]
10. Organoid models in gynaecological oncology research.
Semertzidou A; Brosens JJ; McNeish I; Kyrgiou M
Cancer Treat Rev; 2020 Nov; 90():102103. PubMed ID: 32932156
[TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
Zhou Z; Cong L; Cong X
Front Oncol; 2021; 11():762184. PubMed ID: 35036354
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
13. The case for applying tissue engineering methodologies to instruct human organoid morphogenesis.
Marti-Figueroa CR; Ashton RS
Acta Biomater; 2017 May; 54():35-44. PubMed ID: 28315813
[TBL] [Abstract][Full Text] [Related]
14. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
15. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
16. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids.
Karakasheva TA; Kijima T; Shimonosono M; Maekawa H; Sahu V; Gabre JT; Cruz-Acuña R; Giroux V; Sangwan V; Whelan KA; Natsugoe S; Yoon AJ; Philipone E; Klein-Szanto AJ; Ginsberg GG; Falk GW; Abrams JA; Que J; Basu D; Ferri L; Diehl JA; Bass AJ; Wang TC; Rustgi AK; Nakagawa H
Curr Protoc Stem Cell Biol; 2020 Jun; 53(1):e109. PubMed ID: 32294323
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived organoid models help define personalized management of gastrointestinal cancer.
Aberle MR; Burkhart RA; Tiriac H; Olde Damink SWM; Dejong CHC; Tuveson DA; van Dam RM
Br J Surg; 2018 Jan; 105(2):e48-e60. PubMed ID: 29341164
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
19. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
20. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]